A combination drug containing niacin failed to lower the risk of heart attacks or strokes and even proved harmful for some with vascular disease, a study released Saturday reported.
Cardiology Mar 09, 2013 | 4 / 5 (1) | 0
In a new phase III trial mirabegron, a β3-adrenoceptor agonist, given once daily for 12 weeks, reduced the frequency of incontinence episodes and number of daily urinations, and improved urgency and nocturia in adults with ...
Diseases, Conditions, Syndromes Mar 04, 2013 | not rated yet | 0
(Medical Xpress)—A daily multivitamin supplement may enhance mood and energy, according to new research conducted at Swinburne University of Technology.
Health Mar 04, 2013 | 4 / 5 (2) | 1
(HealthDay)—The U.S. Food and Drug Administration has approved a new drug to treat postmenopausal women who experience pain during sex, the agency announced Tuesday.
Medications Feb 26, 2013 | not rated yet | 0
(HealthDay)—Patients recently diagnosed with type 1 diabetes have greater death of pancreatic β-cells compared with patients with long-standing diabetes, which can be reduced by treatment with teplizumab, ...
Diabetes Feb 26, 2013 | not rated yet | 0
The U.S. Food and Drug Administration on Monday expanded approval of a Bayer cancer pill to treat tumors of the intestinal tract that do not respond to other treatments.
Medications Feb 25, 2013 | not rated yet | 0
(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, ...
Medications Feb 20, 2013 | 4 / 5 (1) | 0 |
(HealthDay)—Low-dose naltrexone treatment is associated with significant reductions in pain in patients with fibromyalgia, according to a study published in the February issue of Arthritis & Rheumatism.
Diseases, Conditions, Syndromes Feb 12, 2013 | 3.5 / 5 (2) | 0
(HealthDay)—Compared with placebo, saw palmetto, even at a dose as high as 960 mg, does not affect serum prostate-specific antigen (PSA) levels in men with lower urinary tract symptoms, according to research ...
Cancer Feb 08, 2013 | not rated yet | 0
(HealthDay)—In acutely ill hospitalized patients, standard-duration rivaroxaban has similar efficacy as enoxaparin in reducing the risk of venous thromboembolism, while extended-duration rivaroxaban has ...
Diseases, Conditions, Syndromes Feb 07, 2013 | not rated yet | 0
In a first-ever comprehensive study of 124 natural product combinations, a team of researchers from the National University of Singapore (NUS) and Tsinghua University, led by Professor Chen Yu Zong from the Department of ...
Medications Feb 07, 2013 | not rated yet | 0
(HealthDay)—Corticorelin acetate (CrA) administration to patients with peritumoral brain edema (PBE) allows the reduction of steroid doses and is associated with reduced incidence and severity of steroid-induced ...
Cancer Feb 06, 2013 | 4 / 5 (1) | 0
It's been said that food is the language of love. If so, can certain foods—or aphrodisiacs—promote romantic feelings or sexual desire?
Health Feb 06, 2013 | 5 / 5 (1) | 0
Among patients with chronic unilateral lateral epicondylalgia ("tennis elbow"), a single injection of corticosteroid medication was associated with poorer outcomes after one year and higher recurrence rates compared with ...
Diseases, Conditions, Syndromes Feb 05, 2013 | not rated yet | 0
(AP)—The maker of Zoloft is being sued in an unusual case alleging the popular antidepressant has no more benefit than a dummy pill. The federal lawsuit, filed in California, argues that patients who took it should be reimbursed ...
Medications Jan 31, 2013 | 1 / 5 (1) | 0